Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtalaya Mining Regulatory News (ATYM)

Share Price Information for Atalaya Mining (ATYM)

Share Price is delayed by 15 minutes
Get Live Data
889.00    3.50 (0.40%)
Bid:
889.50
Ask:
891.00
Spread: 1.50 (0.169%)
Market Cap: £1.37b
ATYM Live PriceLast checked at - London Stock Exchange

Intraday Atalaya Mining Share Chart

Incentive Options Scheme

2 May 2006 07:01

Eastern Mediterranean Res. Pblc LD02 May 2006 AIM: EMED 2 May 2006 EMED INCENTIVE OPTIONS SCHEME Eastern Mediterranean Resources Public Ltd ("EMED") today updates shareholdersof its incentive options scheme and of the issuance of new options to Managementand Directors. Current participation limits and levels are as follows: • Options on issue, 16.5 million versus 17.6 million permissible based on issued capital 70.4 million shares • 3.9 million issued in April 2006 to Officers exercisable at 13.5p per share, being a 15% premium to market • Incentive Options held by Management and Directors or their associates are now as follows: • Mr Anagnostaras-Adams, Managing Director, 6,500,000 of which 1,500,000 are New Options • Mr Cunneen, Head of Exploration, 1,850,000 of which 350,000 are New Options • Dr Constantinides, Head of Development, 800,000 of which 300,000 are New Options • Other Managers, 3,836,000 of which 1,296,000 are New Options • Mr Gordon Toll, Chairman of Directors, 1,450,000 of which 200,000 are New Options • Mr Ronnie Beevor, Non-Executive Director, 1,450,000 of which 200,000 are New Options • Dr Andreas Panayiotou, Non-Executive Director, 725,000 of which 100,000 are New Options Governance of Incentive Scheme • Scheme established at the time of the Company's ordinary Shares being admitted to AIM in May 2005. • The ethos of the scheme is to appropriately incentivise and reward Managers and Directors • Remuneration Committee administers the scheme, advised by Nominated Advisers and legal advisers • Scheme and participation levels normally to be reviewed annually after Company AGM Number of Options • To recognise that remuneration levels are unchanged since Company Admission to AIM and are not high by industry standards • Normally to number no more than twenty per cent (20.0%) of the fully-diluted issued share capital • The maximum limit will decrease as the overall value of EMED increases. By way of illustration once EMED has a market capitalisation of £100 million, the percentage would be circa ten per cent (10.0%). Exercise Periods, Price and Vesting • Normally have exercise periods of six years and vest in 3 equal instalments over the first 2 years • Should be fixed between the prevailing market price at the time of issue and up to 20% premium to market Managing Director Harry Anagnostaras-Adams said, "EMED has started as a smallexploration company, dedicated to a bold mission of establishing a profitablemining house by discovering or buying copper or gold deposits in the Eurasianregion. At this stage our key asset is our people and we are fortunate to haveassembled such an excellent team." EnquiriesEastern Mediterranean Resources Nabarro Wells Parkgreen CommunicationsHarry Anagnostaras-Adams David Nabarro Ana Ribeiro+357 9945 7843 +44 (0) 20 7710 7400 +44 (0) 20 7493 3713www.emed-resources.com www.emed.tv This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Apr 20247:00 amRNSQ1 2024 Operations Update
19th Mar 20247:00 amRNS2023 Annual Results
8th Mar 20247:00 amRNSNotice of 2023 Annual Results
9th Feb 20247:00 amRNSIssue of Equity
18th Jan 20247:00 amRNSQ4 Operations Update and 2024 Production Guidance
21st Dec 20237:01 amRNSUpdate on Move to Main Market
21st Dec 20237:00 amRNSHolding(s) in Company
21st Dec 20237:00 amRNSHolding(s) in Company
20th Dec 20237:00 amRNSHolding(s) in Company
14th Dec 20231:49 pmRNSExtension of Port Handling Agreement
12th Dec 202311:28 amRNSResults of the 2023 Extraordinary General Meeting
12th Dec 20237:00 amRNS2023 Extraordinary General Meeting Statement
1st Dec 20237:00 amRNSHistorical Related Party Transactions
20th Nov 20237:00 amRNSHolding(s) in Company
16th Nov 20237:00 amRNSQ3 and YTD 2023 Financial Results
14th Nov 20237:00 amRNSProposed Re-domiciliation and Notice of EGM
13th Nov 20237:00 amRNSIntention to Move from AIM to Main Market
2nd Nov 20237:00 amRNSNotice of Q3 and YTD 2023 Financial Results
12th Oct 20237:00 amRNSQ3 2023 Operations Update
10th Oct 20233:11 pmRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSInterim Dividend Foreign Exchange Rates
10th Aug 20237:00 amRNSQ2 and H1 2023 Financial Results
27th Jul 20237:00 amRNSNotice of Q2 and H1 2023 Financial Results
20th Jul 20237:00 amRNSFinal Dividend Foreign Exchange Rates & Payment
20th Jul 20237:00 amRNSCorrection to Q2 Provisional Revenue Adjustments
12th Jul 20237:00 amRNSQ2 2023 Operations Update
10th Jul 20237:00 amRNSPDMR Shareholding
29th Jun 20237:00 amRNS2022 Final Dividend Timetable
28th Jun 202311:25 amRNSResults of the 2023 Annual General Meeting
28th Jun 20237:00 amRNS2023 Annual General Meeting Statement
26th Jun 20237:00 amRNSApproval to Cease to be Reporting in Canada
26th Jun 20237:00 amRNSReport on Payments to Governments
1st Jun 20237:00 amRNSNotice of AGM
30th May 20237:00 amRNSApplication to Cease to be a Reporting Issuer
23rd May 20237:00 amRNSGrant of Share Options and PDMR Notification
16th May 20237:00 amRNSPublication of 2022 Sustainability Report
15th May 20237:00 amRNSQ1 2023 Financial Results
2nd May 20237:00 amRNSNotice of Q1 2023 Results
17th Apr 20237:00 amRNSQ1 2023 Operations Update
28th Mar 20237:00 amRNSEnvironmental Authorisation Granted to PMV
24th Mar 20237:00 amRNSFiling of New Riotinto PEA Technical Report
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNS2022 Annual Results
15th Mar 20237:00 amRNSNotice of 2022 Annual Results
13th Mar 20237:00 amRNSUpdate on Voluntary Delisting From The TSX
23rd Feb 20237:00 amRNSResults of New PEA for Riotinto
20th Feb 20237:00 amRNSVoluntary Delisting from the TSX
17th Jan 20237:00 amRNSQ4 Operations Update and 2023 Production Guidance
12th Jan 20237:00 amRNSHolding(s) in Company
24th Nov 20227:00 amRNSUpdate on Exploration Activities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.